Home/OncoLize/Mike de Leeuw

MD

Mike de Leeuw

CEO

Therapeutic Areas

OncoLize Pipeline

Drug	Indication	Phase
ChemGem™ (Gemcitabine)	Pancreatic Cancer	Pre-clinical

Leadership Team at OncoLize

Dr. Leo de Leede

View full OncoLize profile